Corrigendum to “PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis” [EBioMedicine 40 (2019) 290-304]

Detalles Bibliográficos
Autores principales: Rodriguez-Aguayo, Cristian, Bayraktar, Emine, Ivan, Cristina, Aslan, Burcu, Mai, Junhua, He, Guangan, Mangala, Lingegowda S., Jiang, Dahai, Nagaraja, Archana S., Ozpolat, Bulent, Chavez-Reyes, Arturo, Ferrari, Mauro, Mitra, Rahul, Siddik, Zahid H., Shen, Haifa, Yang, Xianbin, Sood, Anil K., Lopez-Berestein, Gabriel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340498/
https://www.ncbi.nlm.nih.gov/pubmed/35914489
http://dx.doi.org/10.1016/j.ebiom.2022.104194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340498/
https://www.ncbi.nlm.nih.gov/pubmed/35914489
http://dx.doi.org/10.1016/j.ebiom.2022.104194

Ejemplares similares